Structure |
Chemical Name |
CAS |
MF |
|
tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate |
474645-25-5 |
C40H59N3O7 |
|
1-Vinylimidazole |
1072-63-5 |
C5H6N2 |
|
2'-CHLORO-2'-DEOXYURIDINE |
4753-04-2 |
C9H11ClN2O5 |
|
FMOC-21-AMINO-4,7,10,13,16,19-HEXAOXAHENEICOSANOIC ACID |
882847-34-9 |
C30H41NO10 |
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA |
27376-76-7 |
C20H34O5 |
|
Posaconazole Impurity 16 |
213381-02-3 |
C37H42F2N8O4 |
|
4,7-DIMETHYLCOUMARIN |
14002-90-5 |
C11H10O2 |
|
5-Fluoroindole |
399-52-0 |
C8H6FN |
|
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
182182-31-6 |
C13H15FN2O2 |
|
5-BRDU 5-bromo-2'-deoxyuridine |
|
|
|
tetramethyl 3,3',3'',3'''-(porphyrin-5,10,15,20-tetrayl)tetrabenzoate |
75286-83-8 |
C52H38N4O8 |
|
7-Chloro-1,2,3,4-tetrahydrobenzo(b)azepin-5-one |
160129-45-3 |
C10H10ClNO |
|
4-methyl-7-nitro- 2H-chromen-2-one |
179897-88-2 |
C10H7NO4 |
|
Cefradine double nucleus |
|
|
|
Fulvestrant intermediate |
1610351-44-4 |
C30H46O6S |
|
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole |
97963-62-7 |
C8H6F2N2OS |
|
ADENYLYL(3'>5')CYTIDINE FREE ACID |
2382-66-3 |
C19H25N8O11P |
|
CEFMETAZOLE MMT ISOMER |
|
|
|
Cyclobutanecarboxylic acid, 3-(methylamino)-, 1-methylethyl ester, cis- |
2136718-64-2 |
C9H17NO2 |
|
Vanadyl Riboside Complex (RVC/VRC) |
|
|
|
Cefminox for system suitability |
|
|
|
Flomoxef Intermediate NaMT |
|
|
|
3,4-(Methylenedioxy)aniline |
14268-66-7 |
C7H7NO2 |
|
Methenolone enanthate |
303-42-4 |
C27H42O3 |
|
8-OXO-DG |
|
|
|
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone |
530084-79-8 |
C18H16BrNO3 |
|
cytidylyl-(5'->3')-guanosine |
4785-04-0 |
C19H25N8O12P |
|
(6R-trans)-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
58233-18-4 |
C15H16N4O6S2 |
|
4-(dimethylammonio)piperidinium dichloride |
4876-59-9 |
C7H18Cl2N2 |
|
Dolutegravir intermediate |
|
|
|
(7S)-Cefuroxime |
|
|
|
5-phenyl-2,3,7-tris(phenylamino)phenazinium chloride |
4935-81-3 |
C36H28ClN5 |
|
1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-3,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,3R)- |
2209874-09-7 |
C12H20N2O3 |
|
6-Methyleneandrost-4-ene-3,17-dione |
19457-55-7 |
C20H26O2 |
|
Prostaglandin F3a |
|
|
|
8-iso Prostaglandin F2a-d4 |
|
|
|
6,7-DIHYDROXY-4-(TRIFLUOROMETHYL)COUMARIN |
82747-36-2 |
C10H5F3O4 |
|
455284-06-7 |
455284-06-7 |
|
|
N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide |
122584-18-3 |
C17H18BrNO4 |
|
4-Chlorodehydromethyltestosterone |
2446-23-3 |
C20H27ClO2 |
|
2'-iodo-2'-deoxyuridine |
4753-03-1 |
C9H11IN2O5 |
|
(1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane |
110567-22-1 |
C20H22O3 |
|
5'-Methoxylaudanosine |
24734-71-2 |
C22H29NO5 |
|
tert-Butyl (1-(hydroxymethyl)cyclopropyl)carbamate |
107017-73-2 |
C9H17NO3 |
|
(+)-Camphor Bromide |
10293-06-8 |
C10H15BrO |
|
Perfluoro(4-methyl-3,6-dioxaoct-7-ene)sulfonyl fluoride |
16090-14-5 |
C7F14O4S |
|
7-METHOXY-4-(TRIFLUOROMETHYL)COUMARIN |
575-04-2 |
C11H7F3O3 |
|
β-NADPH-D |
74784-45-5 |
C21H30N7O17P3 |
|
1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]- |
446292-08-6 |
C22H19N3O6 |
|
3-Iodo-1H-pyrazole |
4522-35-4 |
C3H3IN2 |
|
1-Azepanyl(4,5,6,7-tetrahydro-1H-pyrazolo-[4,3-c]pyridin-3-yl)methanone hydrochloride |
1219982-46-3 |
C13H21ClN4O |
|
Diisopropyl 3,3-dimethoxycyclobutane-1,1-dicarboxylate |
115118-68-8 |
C14H24O6 |
|
(5α,10α)-5,10-Epoxy-estr-9(11)-ene-3,17-dione Cyclic 3-(1,2-Ethanediyl Acetal) |
39931-87-8 |
C20H26O4 |
|
Methyl 5-chloro-6-methylpyrazine-2-carboxylate |
77168-85-5 |
C7H7ClN2O2 |
|
(9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate |
115057-37-9 |
C17H16N2O3 |
|
Inosine API manufacturers |
|
|
|
3’-deoxyinosine |
|
|
|
Acetoxy Ceftazidime Intermediate |
|
|
|
Flomoxef Intermediate FXMT |
|
|
|
4-METHYL 6-HYDROXY 7-ACETOXY COUMARIN |
46895-13-0 |
C12H10O6 |
|
Pyrazole |
288-13-1 |
C3H4N2 |
|
9-OXO-11ALPHA,15S-DIHYDROXY-PROST-13E-EN-1-OIC-3,3,4,4-D4 ACID |
211105-33-8 |
C20H30D4O5 |
|
7,10-Dioxa-2,5-diazaundecanoic acid, 4,9-dioxo-11-phenyl-, 9H-fluoren-9-ylmethyl ester |
1599440-07-9 |
C27H26N2O6 |
|
2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN |
58336-35-9 |
C15H15NO2 |
|
RebaMipide interMediate product |
169809-59-0 |
C19H16ClN2NaO4 |
|
tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
866084-31-3 |
C33H45N7O4 |
|
(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one |
415927-29-6 |
C34H51F5O3S |
|
5-Bromo-2-methylbenzoic acid |
79669-49-1 |
C8H7BrO2 |
|
EthanediaMide iMpurity F hcl |
482375-18-8 |
C2H4N2O2 |
|
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1702274-61-0 |
C20H25N5 |
|
(3S)-10-Fluoro-2,3-dihydro-3-Methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid |
117620-84-5 |
C13H10FNO4 |
|
2-Chloro-4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidine |
1269440-58-5 |
C10H10ClIN4 |
|
Coumarin |
15938-72-4 |
C28H22O9 |
|
4-TERT-BUTOXYCARBONYLAMINO-PIPERIDINE-1,4-DICARBOXYLIC ACID MONOBENZYL ESTER |
252720-32-4 |
C19H26N2O6 |
|
Engelide intermediate |
|
|
|
Ethyl 4-acetoxy-6,7-difluoro-2-(ethylthio)quinoline-3-carboxylate |
154330-68-4 |
C16H15F2NO4S |
|
(5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride |
1373116-04-1 |
C25H37ClF2N2OSi |
|
Cefiderocol |
1225208-94-5 |
C30H34ClN7O10S2 |
|
2,3-Dimethylbenzyl alcohol |
13651-14-4 |
C9H12O |
|
(1R)-(+)-TRANS-PINANE |
4863-59-6 |
C10H18 |
|
ABT-494 intermediate |
1428243-24-6 |
C15H19NO4 |
|
5-Methyl-4-isoxazolecarboxylic acid |
42831-50-5 |
C5H5NO3 |
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN E2 |
363-23-5 |
C20H32O5 |
|
L-(+)-Ergothioneine |
497-30-3 |
C9H15N3O2S |
|
Material intermediate |
162039-67-0 |
C18H14N4 |
|
(3-BROMOACETYL)COUMARIN |
29310-88-1 |
C11H7BrO3 |
|
Primary Prostaglandin Metabolite LC-MS Mixture |
|
|
|
Sugammadex sodium Heptabromide intermediate |
|
|
|
Rabacfosadine succinate |
1431856-99-3 |
C25H41N8O10P |
|
Cefotiam (6R,7S) isomer reference |
|
|
|
Ceftiofur Double Mother Nucleus |
|
|
|
7S-Cephalexin |
|
|
|
(6R,7S)-Latamoxef MotherNucleus |
|
|
|
COUMARIN 6 |
88241-65-0 |
C15H12O2 |
|
FLUTICASONE PROPIONATE INTERMEDIATE |
80474-45-9 |
C24H30F2O5S |
|
2-Chloro-5-methylpyrazine |
59303-10-5 |
C5H5ClN2 |
|
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol |
142569-70-8 |
C29H28ClNO2 |
|
1,3-Benzodioxole-5-acetic acid methyl ester |
326-59-0 |
C10H10O4 |
|
Tert-Butyl 4-Vinylphenyl Carbonate |
87188-51-0 |
C13H16O3 |
|
4-[3-(Trifluoromethyl)phenyl]-1-piperazineethanol |
40004-29-3 |
C13H17F3N2O |